Lorpucitinib
Lorpucitinib (JNJ-64251330) is an orally active pan-JAK inhibitor with good enteric selectivity and safety. Lorpucitinib can inhibit the JAK/STAT pathway and reduce the levels of inflammatory biomarkers in serum. Lorpucitinib can be used in the research of familial adenomatous polyposis and gastrointestinal inflammatory diseases[1][2].
Product Specifications
CAS Number
2230282-02-5
Product Name Alternative
JNJ-64251330
UNSPSC
12352005
Target
JAK; STAT
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lorpucitinib.html
Purity
99.95
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NCC(C)(O)C)CC1=NC2=CN=C(NC=C3)C3=C2N1[C@H]4CC[C@H](CC#N)CC4
Molecular Formula
C22H28N6O2
Molecular Weight
408.50
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SARS-CoV-2 Spike RBD Protein (K417N, L452R, T478K), His Tag (MALS verified)
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF594 conjugate, 0.1mg/mL
Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/3282), Biotin conjugate, 0.1mg/mL
2-(tert-Butylamino)-4-chloro-6-cyclopropylamino-1,3,5-triazine-d9
